FIELD: medicine; ophthalmology.
SUBSTANCE: invention is intended for treating inflammatory eye diseases in a subject. Method of treating an inflammatory eye disease in a subject in need of such treatment comprises administering a pharmaceutical composition, containing a therapeutically effective amount of at least one formyl peptide receptor 2 (FPR2) agonist. Inflammatory eye disease is selected from the following: uveitis, dry eye, keratitis, allergic eye disease, infectious keratitis, uveitis, herpetic keratitis, corneal angiogenesis, lymphangiogenesis, retinitis, choroiditis, acute multifocal placoid pigment epitheliopathy, Behcet's disease, postoperative corneal healing, wet and dry age-related macular degeneration (AMD).
EFFECT: using the invention enables improving the effectiveness of treating the inflammatory eye disease, including by accelerating the healing and re-epithelization of the corneal injury.
5 cl, 3 dwg, 4 tbl
